Non-invasive monitoring of DNAPL migration through a saturated porous medium using electrical impedance tomography

Electrical impedance tomography (EIT) was used to monitor the movement of a fluorinated hydrocarbon dense nonaqueous phase liquid (DNAPL) through a saturated porous medium within a laboratory column. Impedance measurements were made using a horizontal plane of 12 electrodes positioned at regular intervals around the centre of the column. A 2D inversion algorithm, which incorporated the cylindrical geometry of the column, was used to reconstruct resistivity and phase images from the measured data. Differential time-lapse images of DNAPL movement past the plane of electrodes were generated by the cell-by-cell subtraction of resistivity and phase baseline models from those associated with the DNAPL release stage of the experiment. The DNAPL pulse was clearly delineated as resistive anomalies in the differential time-lapse resistivity images. The spatial extent of the resistive anomalies indicated that in addition to vertical migration, some lateral spreading of the DNAPL had occurred. Residual contamination could be detected after quasi-static conditions were reestablished. Residual DNAPL saturation was estimated from the resistivity model data by applying Archie's second equation. Despite significant measured phase changes due to DNAPL contamination, the differential phase images revealed only weak anomalies associated with DNAPL flow; these anomalies could be seen only in the initial stages of the experiment during peak flow through the plane of electrodes

Psychotherapieforschung

These guidelines address the diagnosis and management of atherosclerotic, aneurysmal, and thromboembolic peripheral arterial diseases (PADs). The clinical manifestations of PAD are a major cause of acute and chronic illness, are associated with decrements in functional capacity and quality of life, cause limb amputation, and increase the risk of death. Whereas the term “peripheral arterial disease” encompasses a large series of disorders that affect arterial beds exclusive of the coronary arteries, this writing committee chose to limit the scope of the work of this document to include the disorders of the abdominal aorta, renal and mesenteric arteries, and lower extremity arteries. The purposes of the full guidelines are to (a) aid in the recognition, diagnosis, and treatment of PAD of the aorta and lower extremities, addressing its prevalence, impact on quality of life, cardiovascular ischemic risk, and risk of critical limb ischemia (CLI); (b) aid in the recognition, diagnosis, and treatment of renal and visceral arterial diseases; and (c) improve the detection and treatment of abdominal and branch artery aneurysms. Clinical management guidelines for other arterial beds (e.g., the thoracic aorta, carotid and vertebral arteries, and upper-extremity arteries) have been excluded from the current guidelines to focus on the infradiaphragmatic arterial system and in recognition of the robust evidence base that exists for the aortic, visceral, and lower extremity arteries